T cell responses and clinical outcomes in pancreatic and colorectal cancer patients with minimal residual disease in AMPLIFY-201, a phase 1 trial of a first-in-class amphiphile lymph node targeted mutant KRAS vaccine

Zev A. Wainberg,Shubham Pant, Colin D. Weekes,Muhammad Furqan, Pashtoon M. Kasi, Craig E. Devoe,Alexis D. Leal, Vincent Chung,James R. Perry, Lochana Seenappa,Lisa K. McNeil, Esther Welkowsky,Peter C. DeMuth, Christopher M. Haqq, Eileen M. O'Reilly

CANCER RESEARCH(2024)

引用 0|浏览1
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要